Curis Inc (CRIS)
15.85
-0.47
(-2.88%)
USD |
NASDAQ |
May 10, 16:00
15.85
0.00 (0.00%)
After-Hours: 20:00
Curis Free Cash Flow: -38.43M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -38.43M |
| September 30, 2023 | -40.52M |
| June 30, 2023 | -45.46M |
| March 31, 2023 | -49.72M |
| December 31, 2022 | -54.75M |
| September 30, 2022 | -50.66M |
| June 30, 2022 | -47.09M |
| March 31, 2022 | -41.27M |
| December 31, 2021 | -37.62M |
| September 30, 2021 | -35.18M |
| June 30, 2021 | -31.61M |
| March 31, 2021 | -30.34M |
| December 31, 2020 | -26.42M |
| September 30, 2020 | -26.28M |
| June 30, 2020 | -26.95M |
| March 31, 2020 | -28.27M |
| December 31, 2019 | -26.25M |
| September 30, 2019 | -25.59M |
| June 30, 2019 | -27.11M |
| March 31, 2019 | -27.34M |
| December 31, 2018 | -30.15M |
| September 30, 2018 | -32.76M |
| June 30, 2018 | -41.03M |
| March 31, 2018 | -43.39M |
| December 31, 2017 | -48.54M |
| Date | Value |
|---|---|
| September 30, 2017 | -50.44M |
| June 30, 2017 | -41.54M |
| March 31, 2017 | -43.34M |
| December 31, 2016 | -36.14M |
| September 30, 2016 | -37.56M |
| June 30, 2016 | -34.48M |
| March 31, 2016 | -30.16M |
| December 31, 2015 | -29.94M |
| September 30, 2015 | -23.79M |
| June 30, 2015 | -21.37M |
| March 31, 2015 | -19.37M |
| December 31, 2014 | -16.90M |
| September 30, 2014 | -17.72M |
| June 30, 2014 | -15.45M |
| March 31, 2014 | -10.64M |
| December 31, 2013 | -9.693M |
| September 30, 2013 | -17.56M |
| June 30, 2013 | -21.93M |
| March 31, 2013 | -23.59M |
| December 31, 2012 | -15.30M |
| September 30, 2012 | 6.780M |
| June 30, 2012 | 6.541M |
| March 31, 2012 | 3.771M |
| December 31, 2011 | -4.824M |
| September 30, 2011 | -17.40M |
Free Cash Flow Range, Past 5 Years
-54.75M
Minimum
Dec 2022
-25.59M
Maximum
Sep 2019
-36.29M
Average
-35.18M
Median
Sep 2021
Free Cash Flow Benchmarks
| AIM ImmunoTech Inc | -21.85M |
| Perspective Therapeutics Inc | -37.98M |
| Protalix BioTherapeutics Inc | -2.467M |
| Electromed Inc | 3.653M |
| Armata Pharmaceuticals Inc | -55.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -10.19M |
| Cash from Investing (Quarterly) | 14.52M |
| Cash from Financing (Quarterly) | -2.118M |
| Free Cash Flow Per Share (Quarterly) | -1.763 |
| Free Cash Flow to Equity (Quarterly) | -10.19M |
| Free Cash Flow Yield | -45.83% |